Merck settles patent dispute on cholesterol drug
Merck settles patent dispute on cholesterol drug Merck & Co. said Monday it settled a patent dispute with Glenmark Pharmaceuticals on the cholesterol drug Zetia, one of its best-selling products. Read more on AP via Yahoo! News